BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lamers MM, Haagmans BL. SARS-CoV-2 pathogenesis. Nat Rev Microbiol 2022. [PMID: 35354968 DOI: 10.1038/s41579-022-00713-0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 42] [Article Influence: 33.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang W, Hu Y, Li B, Wang H, Shen J. Applications of nanobodies in the prevention, detection, and treatment of the evolving SARS-CoV-2. Biochem Pharmacol 2023;208:115401. [PMID: 36592707 DOI: 10.1016/j.bcp.2022.115401] [Reference Citation Analysis]
2 Chen J, Li Y, Liu Z. Functional nucleic acids as potent therapeutics against SARS-CoV-2 infection. Cell Rep Phys Sci 2023;:101249. [PMID: 36714073 DOI: 10.1016/j.xcrp.2023.101249] [Reference Citation Analysis]
3 Brindani N, Munafò F, Menichetti A, Donati E, Nigro M, Ottonello G, Armirotti A, De Vivo M. Design, synthesis, docking, and biochemical characterization of non-nucleoside SARS-CoV-2 RdRp inhibitors. Bioorg Med Chem 2023;80:117179. [PMID: 36716583 DOI: 10.1016/j.bmc.2023.117179] [Reference Citation Analysis]
4 Siregar J, Darmadi D. Serum Homocysteine Level and Severity of Coronavirus Disease-2019 (COVID-19). Rom J Intern Med 2023. [PMID: 36657014 DOI: 10.2478/rjim-2023-0002] [Reference Citation Analysis]
5 Carabelli AM, Peacock TP, Thorne LG, Harvey WT, Hughes J, Peacock SJ, Barclay WS, de Silva TI, Towers GJ, Robertson DL; COVID-19 Genomics UK Consortium. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat Rev Microbiol 2023;:1-16. [PMID: 36653446 DOI: 10.1038/s41579-022-00841-7] [Reference Citation Analysis]
6 Zyoud SH, Shakhshir M, Abushanab AS, Koni A, Shahwan M, Jairoun AA, Al-Jabi SW. Mapping the output of the global literature on the links between gut microbiota and COVID-19. J Health Popul Nutr 2023;42:3. [PMID: 36653831 DOI: 10.1186/s41043-023-00346-w] [Reference Citation Analysis]
7 Reddy K, Nichol A, McAuley DF. Galectin-3 Inhibition in COVID-19. Am J Respir Crit Care Med 2023;207:118-20. [PMID: 36154818 DOI: 10.1164/rccm.202209-1758ED] [Reference Citation Analysis]
8 Cheng N, Liu M, Li W, Sun B, Liu D, Wang G, Shi J, Li L. Protein post-translational modification in SARS-CoV-2 and host interaction. Front Immunol 2022;13:1068449. [PMID: 36713387 DOI: 10.3389/fimmu.2022.1068449] [Reference Citation Analysis]
9 Noureddine S, Roux-Claudé P, Laurent L, Ritter O, Dolla P, Karaer S, Claudé F, Eberst G, Westeel V, Barnig C. Evaluation of long-term sequelae by cardiopulmonary exercise testing 12 months after hospitalization for severe COVID-19. BMC Pulm Med 2023;23:13. [PMID: 36635717 DOI: 10.1186/s12890-023-02313-x] [Reference Citation Analysis]
10 Akman B, Kavani O, Yücel Y, Çifcibaşi MS, Hal RS, Bakar C. COVİD-19 pandemisinin tıp fakültesi 1.sınıf öğrencilerinde yarattığı depresif eğilim ve ilişkili faktörlerin incelenmesi. Troia Med J 2023. [DOI: 10.55665/troiamedj.1197244] [Reference Citation Analysis]
11 Milota T, Smetanova J, Bartunkova J. Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies. Pathogens 2023;12. [PMID: 36678457 DOI: 10.3390/pathogens12010109] [Reference Citation Analysis]
12 Cong Z, Yang C, Zeng Z, Wu C, Zhao F, Shen Z, Xiao H, Zhu X. α(1)-adrenoceptor stimulation ameliorates lipopolysaccharide-induced lung injury by inhibiting alveolar macrophage inflammatory responses through NF-κB and ERK1/2 pathway in ARDS. Front Immunol 2022;13:1090773. [PMID: 36685596 DOI: 10.3389/fimmu.2022.1090773] [Reference Citation Analysis]
13 Gong HH, Worley MJ, Carver KA, Goldstein DR, Deng JC. Neutrophils drive pulmonary vascular leakage in MHV-1 infection of susceptible A/J mice. Front Immunol 2022;13:1089064. [PMID: 36685578 DOI: 10.3389/fimmu.2022.1089064] [Reference Citation Analysis]
14 Lazarus HM, Pitts K, Wang T, Lee E, Buchbinder E, Dougan M, Armstrong DG, Paine R 3rd, Ragsdale CE, Boyd T, Rock EP, Gale RP. Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders. Front Immunol 2022;13:1069444. [PMID: 36685591 DOI: 10.3389/fimmu.2022.1069444] [Reference Citation Analysis]
15 Rizzi M, Tonello S, D'Onghia D, Sainaghi PP. Gas6/TAM Axis Involvement in Modulating Inflammation and Fibrosis in COVID-19 Patients. Int J Mol Sci 2023;24. [PMID: 36674471 DOI: 10.3390/ijms24020951] [Reference Citation Analysis]
16 Nicollete DRP, Benedetti R, Valença BA, Kuniyoshi KK, de Jesus TCS, Gevaerd A, Santiago EB, de Almeida BMM, Júnior SRR, Figueredo MVM. Cost aware strategies for sensitivity enhancement in a SARS-CoV-2 antigen test prototype: insertion of a cotton intermembrane doubles analytical sensitivity.. [DOI: 10.21203/rs.3.rs-2350797/v1] [Reference Citation Analysis]
17 McColl ER, Croyle MA, Zamboni WC, Honer WG, Heise M, Piquette-Miller M, Goralski KB. COVID-19 Vaccines and the Virus: Impact on Drug Metabolism and Pharmacokinetics. Drug Metab Dispos 2023;51:130-41. [PMID: 36273826 DOI: 10.1124/dmd.122.000934] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Meng Y, Lin S, Niu K, Ma Z, Lin H, Fan H. Vimentin affects inflammation and neutrophil recruitment in airway epithelium during Streptococcus suis serotype 2 infection. Vet Res 2023;54:7. [PMID: 36717839 DOI: 10.1186/s13567-023-01135-3] [Reference Citation Analysis]
19 Kala M, Ahmad S, Dhebane M, Das K, Raturi M, Tyagi M, Kusum A. A Cross-Sectional Comparative Characterization of Hematological Changes in Patients with COVID-19 Infection, Non-COVID Influenza-like Illnesses and Healthy Controls. Viruses 2022;15. [PMID: 36680172 DOI: 10.3390/v15010134] [Reference Citation Analysis]
20 An K, Zhu X, Yan J, Xu P, Hu L, Bai C. A systematic study on the binding affinity of SARS-CoV-2 spike protein to antibodies. AIMS Microbiol 2022;8:595-611. [PMID: 36694585 DOI: 10.3934/microbiol.2022038] [Reference Citation Analysis]
21 Schiano Moriello A, Roviezzo F, Iannotti FA, Rea G, Allarà M, Camerlingo R, Verde R, Di Marzo V, Petrosino S. First Evidence of the Protective Effects of 2-Pentadecyl-2-Oxazoline (PEA-OXA) in In Vitro Models of Acute Lung Injury. Biomolecules 2022;13. [PMID: 36671418 DOI: 10.3390/biom13010033] [Reference Citation Analysis]
22 Li C, Che B, Deng L. Electrochemical Biosensors Based on Carbon Nanomaterials for Diagnosis of Human Respiratory Diseases. Biosensors (Basel) 2022;13. [PMID: 36671847 DOI: 10.3390/bios13010012] [Reference Citation Analysis]
23 Taskin MH, Yazici Z, Barry G. A prevalence study of COVID-19 among healthcare workers in a pandemic hospital in the Samsun province of Turkey. PLoS One 2022;17:e0279067. [PMID: 36548268 DOI: 10.1371/journal.pone.0279067] [Reference Citation Analysis]
24 Aristotelous AC, Chen A, Forest MG. A hybrid discrete-continuum model of immune responses to SARS-CoV-2 infection in the lung alveolar region, with a focus on interferon induced innate response. J Theor Biol 2022;555:111293. [PMID: 36208668 DOI: 10.1016/j.jtbi.2022.111293] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Antonazzo IC, Fornari C, Rozza D, Conti S, Di Pasquale R, Cortesi PA, Kaleci S, Ferrara P, Zucchi A, Maifredi G, Silenzi A, Cesana G, Mantovani LG, Mazzaglia G. Statins Use in Patients with Cardiovascular Diseases and COVID-19 Outcomes: An Italian Population-Based Cohort Study. J Clin Med 2022;11. [PMID: 36556112 DOI: 10.3390/jcm11247492] [Reference Citation Analysis]
26 Wei S, Chen G, Ouyang X, Hong Y, Pan Y. Clinical features of elderly patients with COVID-19 in Wuhan, China. World J Clin Cases 2022;10:12890-12898. [DOI: 10.12998/wjcc.v10.i35.12890] [Reference Citation Analysis]
27 Huang SF, Ying-Jung Wu A, Shin-Jung Lee S, Huang YS, Lee CY, Yang TL, Wang HW, Chen HJ, Chen YC, Ho TS, Kuo CF, Lin YT; GREAT working group. COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis. J Microbiol Immunol Infect 2022:S1684-1182(22)00285-7. [PMID: 36586744 DOI: 10.1016/j.jmii.2022.12.004] [Reference Citation Analysis]
28 Gothwal M, Verma R, Goyal P, Gupta P, Pandey VP. "STUDY OF FREQUENCY OF NEWLY DIAGNOSED DIABESTES IN PATIENTS RECOVERING FROM SARS CoV-2 INFECTION ATTENDING FOLLOW UP OPD IN A TERTIARY CARE CENTRE”. GLOBAL JOURNAL FOR RESEARCH ANALYSIS 2022. [DOI: 10.36106/gjra/1401947] [Reference Citation Analysis]
29 Madhu P, Davey N, Ivarsson Y. How viral proteins bind short linear motifs and intrinsically disordered domains. Essays in Biochemistry 2022. [DOI: 10.1042/ebc20220047] [Reference Citation Analysis]
30 Khan M, Clijsters M, Choi S, Backaert W, Claerhout M, Couvreur F, Van Breda L, Bourgeois F, Speleman K, Klein S, Van Laethem J, Verstappen G, Dereli AS, Yoo SJ, Zhou H, Dan Do TN, Jochmans D, Laenen L, Debaveye Y, De Munter P, Gunst J, Jorissen M, Lagrou K, Meersseman P, Neyts J, Thal DR, Topsakal V, Vandenbriele C, Wauters J, Mombaerts P, Van Gerven L. Anatomical barriers against SARS-CoV-2 neuroinvasion at vulnerable interfaces visualized in deceased COVID-19 patients. Neuron 2022;110:3919-3935.e6. [PMID: 36446381 DOI: 10.1016/j.neuron.2022.11.007] [Reference Citation Analysis]
31 Dubler S, Turan ÖC, Schmidt KD, Rath PM, Verhasselt HL, Maier S, Skarabis A, Brenner T, Herbstreit F. Effect of Dexamethasone on the Incidence and Outcome of COVID-19 Associated Pulmonary Aspergillosis (CAPA) in Critically Ill Patients during First- and Second Pandemic Wave-A Single Center Experience. Diagnostics (Basel) 2022;12. [PMID: 36553055 DOI: 10.3390/diagnostics12123049] [Reference Citation Analysis]
32 Al-hakeim HK, Al-rubaye HT, Jubran AS, Almulla AF, Moustafa SR, Maes M. Increased insulin resistance due to Long COVID is associated with depressive symptoms and partly predicted by the inflammatory response during acute infection.. [DOI: 10.1101/2022.12.01.22283011] [Reference Citation Analysis]
33 Puhach O, Meyer B, Eckerle I. SARS-CoV-2 viral load and shedding kinetics. Nat Rev Microbiol 2022;:1-15. [PMID: 36460930 DOI: 10.1038/s41579-022-00822-w] [Reference Citation Analysis]
34 Ferreira LC, Gomes CEM, Rodrigues-Neto JF, Jeronimo SMB. Genome-wide association studies of COVID-19: Connecting the dots. Infect Genet Evol 2022;106:105379. [PMID: 36280088 DOI: 10.1016/j.meegid.2022.105379] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Yang Z, Wang W, Qi Y, Yang Y, Chen CH, Liu JZ, Chu GX, Bao GH. Exploring new catechin derivatives as SARS-CoV-2 M(pro) inhibitors from tea by molecular networking, surface plasma resonance, enzyme inhibition, induced fit docking, and metadynamics simulations. Comput Biol Med 2022;151:106288. [PMID: 36401970 DOI: 10.1016/j.compbiomed.2022.106288] [Reference Citation Analysis]
36 Karami H, Karimi Z, Karami N. SARS-CoV-2 in brief: from virus to prevention. Osong Public Health Res Perspect 2022;13:394-406. [PMID: 36617546 DOI: 10.24171/j.phrp.2022.0155] [Reference Citation Analysis]
37 Santos HM, Carvalho LB, Lodeiro C, Martins G, Gomes IL, D. T. Antunes W, Correia V, Almeida-santos MM, Rebelo-de-andrade H, Matos AP, Capelo J. “How to dissect viral infections and their interplay with the host-proteome by immunoaffinity and mass spectrometry: A tutorial.”. Microchemical Journal 2022. [DOI: 10.1016/j.microc.2022.108323] [Reference Citation Analysis]
38 Khan MZI, Nazli A, Al-Furas H, Asad MI, Ajmal I, Khan D, Shah J, Farooq MA, Jiang W. An overview of viral mutagenesis and the impact on pathogenesis of SARS-CoV-2 variants. Front Immunol 2022;13:1034444. [PMID: 36518757 DOI: 10.3389/fimmu.2022.1034444] [Reference Citation Analysis]
39 Lustig G, Ganga Y, Rodel H, Tegally H, Jackson L, Cele S, Khan K, Jule Z, Reedoy K, Karim F, Bernstein M, Moosa MS, Archary D, de Oliveira T, Lessells R, Abdool Karim SS, Sigal A. SARS-CoV-2 evolves increased infection elicited cell death and fusion in an immunosuppressed individual.. [DOI: 10.1101/2022.11.23.22282673] [Reference Citation Analysis]
40 Mcmanus D, Davis M, Ortiz A, Britto C, Dela Cruz CS, Topal J. Immunomodulatory agents for COVID-19 pneumonia. Clinics in Chest Medicine 2022. [DOI: 10.1016/j.ccm.2022.11.009] [Reference Citation Analysis]
41 Cegolon L, Mastrangelo G, Emanuelli E, Camerotto R, Spinato G, Frezza D. Early Negativization of SARS-CoV-2 Infection by Nasal Spray of Seawater plus Additives: The RENAISSANCE Open-Label Controlled Clinical Trial. Pharmaceutics 2022;14. [PMID: 36432693 DOI: 10.3390/pharmaceutics14112502] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Martinelli N, Rigoni AM, De Marchi S, Osti N, Donini M, Montagnana M, Castagna A, Pattini P, Udali S, De Franceschi L, Tinazzi E, Mazzi F, Moruzzi S, Argentino G, Delfino L, Sartori G, Azzini AM, Tacconelli E, Van Dreden P, Lippi G, Girelli D, Olivieri O, Friso S, Pizzolo F. High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis. Diagnostics (Basel) 2022;12. [PMID: 36428852 DOI: 10.3390/diagnostics12112792] [Reference Citation Analysis]
43 Mendez-cortina Y, Rodriguez-perea AL, Chvatal-medina M, Lopera TJ, Alvarez-mesa N, Rodas-marín JK, Moncada DC, Rugeles MT, Velilla PA. Dynamics of humoral immune response in SARS-CoV-2 infected individuals with different clinical stages. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1007068] [Reference Citation Analysis]
44 Reyes S, Rizzo E, Ting A, Dikici E, Daunert S, Deo SK. Metal organic framework encapsulated tamavidin-Gluc reporter: application in COVID-19 spike antigen bioluminescent immunoassay. Sens Diagn 2022;1:1198-208. [PMID: 36561132 DOI: 10.1039/d2sd00145d] [Reference Citation Analysis]
45 Wang D, Kumar V, Burnham KL, Mentzer AJ, Marsden BD, Knight JC. COMBATdb: a database for the COVID-19 Multi-Omics Blood ATlas. Nucleic Acids Res 2023;51:D896-905. [PMID: 36353986 DOI: 10.1093/nar/gkac1019] [Reference Citation Analysis]
46 Planchais C, Reyes-Ruiz A, Lacombe R, Zarantonello A, Lecerf M, Revel M, Roumenina LT, Atanasov BP, Mouquet H, Dimitrov JD. Evolutionary trajectory of receptor binding specificity and promiscuity of the spike protein of SARS-CoV-2. Protein Sci 2022;31:e4447. [PMID: 36305765 DOI: 10.1002/pro.4447] [Reference Citation Analysis]
47 Mao Y, Wang Z, Yao C, Zeng Q, Cheng W, Zhang S, Chen S, Sheng C. The Food and Drug Administration-approved antipsychotic drug trifluoperazine, a calmodulin antagonist, inhibits viral replication through PERK-eIF2α axis. Front Microbiol 2022;13. [DOI: 10.3389/fmicb.2022.979904] [Reference Citation Analysis]
48 Lyu M, Huang M, Zeng K, Li L, Khoury JD, Nishimoto M, Ma H, Sadeghi T, Mukherjee S, Slutsky AS, Flowers CR, Parmar S. Allogeneic cord blood regulatory T cells can resolve lung inflammation. Cytotherapy 2022. [DOI: 10.1016/j.jcyt.2022.10.009] [Reference Citation Analysis]
49 Polkinghorne A, Branley JM. Medications for early treatment of COVID-19 in Australia. Med J Aust 2022;217 Suppl 9:S7-S13. [PMID: 36273391 DOI: 10.5694/mja2.51750] [Reference Citation Analysis]
50 Samuel JG, Malgija B, Ebenezer C, Solomon RV. Insight into designing of 2-pyridone derivatives for COVID-19 drug discovery - A computational study. Struct Chem 2022. [DOI: 10.1007/s11224-022-02076-x] [Reference Citation Analysis]
51 Bulatova N, Younes S, Arabiyat M, Abukaff A, Madanat S, Alqudah E, Hamati A, Halawa F, Younes A. Use of traditional and complementary medicine for COVID 19 prophylaxis among healthcare professionals and students in Jordan: A cross-sectional study. PLoS One 2022;17:e0276015. [PMID: 36264917 DOI: 10.1371/journal.pone.0276015] [Reference Citation Analysis]
52 Nishimura K, Kitazawa H, Kawahata T, Yuhara K, Masuya T, Kuroita T, Waki K, Koike S, Isobe M, Kurosawa N. The development of a highly sensitive and quantitative SARS-CoV-2 rapid antigen test applying newly developed monoclonal antibodies to an automated chemiluminescent flow-through membrane immunoassay device.. [DOI: 10.21203/rs.3.rs-2106847/v1] [Reference Citation Analysis]
53 Potere N, Del Buono MG, Caricchio R, Cremer PC, Vecchié A, Porreca E, Dalla Gasperina D, Dentali F, Abbate A, Bonaventura A. Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications. EBioMedicine 2022;85:104299. [PMID: 36209522 DOI: 10.1016/j.ebiom.2022.104299] [Reference Citation Analysis]
54 Zhang L, Xia H, Du S, Zhao N, Zhang X, Pan Q, Xu S, He Z, Yi Z, Chai J. Carrier-free curcumin nanoassemblies for enhancing therapy effects in inflammation related disease. Materials & Design 2022;222:111087. [DOI: 10.1016/j.matdes.2022.111087] [Reference Citation Analysis]
55 Faizan MI, Chaudhuri R, Sagar S, Albogami S, Chaudhary N, Azmi I, Akhtar A, Ali SM, Kumar R, Iqbal J, Joshi MC, Kharya G, Seth P, Roy SS, Ahmad T. NSP4 and ORF9b of SARS-CoV-2 Induce Pro-Inflammatory Mitochondrial DNA Release in Inner Membrane-Derived Vesicles. Cells 2022;11:2969. [DOI: 10.3390/cells11192969] [Reference Citation Analysis]
56 Harte JV, Wakerlin SL, Lindsay AJ, Mccarthy JV, Coleman-vaughan C. Metalloprotease-Dependent S2′-Activation Promotes Cell–Cell Fusion and Syncytiation of SARS-CoV-2. Viruses 2022;14:2094. [DOI: 10.3390/v14102094] [Reference Citation Analysis]
57 Noureddine S, Roux-claudé P, Laurent L, Ritter O, Dolla P, Karaer S, Claudé F, Eberst G, Westeel V, Barnig C. Evaluation of long-term sequelae by cardiopulmonary exercise testing 12 months after hospitalization for critical COVID-19.. [DOI: 10.1101/2022.09.12.22279779] [Reference Citation Analysis]
58 Aramyan S, Mcgregor K, Sandeep S, Haczku A. SP-A binding to the SARS-CoV-2 spike protein using hybrid quantum and classical in silico modeling and molecular pruning by Quantum Approximate Optimization Algorithm (QAOA) Based MaxCut with ZDOCK. Front Immunol 2022;13:945317. [DOI: 10.3389/fimmu.2022.945317] [Reference Citation Analysis]
59 DeWolf S, Laracy JC, Perales MA, Kamboj M, van den Brink MRM, Vardhana S. SARS-CoV-2 in immunocompromised individuals. Immunity 2022:S1074-7613(22)00500-3. [PMID: 36182669 DOI: 10.1016/j.immuni.2022.09.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 da Silva SJR, do Nascimento JCF, Germano Mendes RP, Guarines KM, Targino Alves da Silva C, da Silva PG, de Magalhães JJF, Vigar JRJ, Silva-Júnior A, Kohl A, Pardee K, Pena L. Two Years into the COVID-19 Pandemic: Lessons Learned. ACS Infect Dis 2022;8:1758-814. [PMID: 35940589 DOI: 10.1021/acsinfecdis.2c00204] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
61 Zong X, Wang X, Liu Y, Li Z, Wang W, Wei D, Chen Z. Antiplatelet therapy for patients with COVID-19: Systematic review and meta-analysis of observational studies and randomized controlled trials. Front Med 2022;9. [DOI: 10.3389/fmed.2022.965790] [Reference Citation Analysis]
62 Xian J, Huang H, Huang G, Zhou R, Yang M, Qiu Y, Bi L, Su Z, Xiao F, Shan H, Jin H. A Positron Emission Tomography Tracer Targeting the S2 Subunit of SARS-CoV-2 in Extrapulmonary Infections. Mol Pharm 2022. [PMID: 36067000 DOI: 10.1021/acs.molpharmaceut.2c00584] [Reference Citation Analysis]
63 Bartolomeo CS, Lemes RMR, Morais RL, Pereria GC, Nunes TA, Costa AJ, de Barros Maciel RM, Braconi CT, Maricato JT, Janini LMR, Okuda LH, Lee KS, Prado CM, Ureshino RP, Stilhano RS. SARS-CoV-2 infection and replication kinetics in different human cell types: The role of autophagy, cellular metabolism and ACE2 expression. Life Sci 2022;308:120930. [PMID: 36075471 DOI: 10.1016/j.lfs.2022.120930] [Reference Citation Analysis]
64 Bai H, Ingber DE. What Can an Organ-on-a-Chip Teach Us About Human Lung Pathophysiology? Physiology (Bethesda) 2022;37:0. [PMID: 35658627 DOI: 10.1152/physiol.00012.2022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
65 Martins M, do Nascimento GM, Nooruzzaman M, Yuan F, Chen C, Caserta LC, Miller AD, Whittaker GR, Fang Y, Diel DG. The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection. J Virol 2022;:e0096122. [PMID: 36000850 DOI: 10.1128/jvi.00961-22] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Musazadeh V, Karimi A, Bagheri N, Jafarzadeh J, Sanaei S, Vajdi M, Karimi M, Niazkar HR. The favorable impacts of silibinin polyphenols as adjunctive therapy in reducing the complications of COVID-19: A review of research evidence and underlying mechanisms. Biomed Pharmacother 2022;154:113593. [PMID: 36027611 DOI: 10.1016/j.biopha.2022.113593] [Reference Citation Analysis]
67 Selickman J, Vrettou CS, Mentzelopoulos SD, Marini JJ. COVID-19-Related ARDS: Key Mechanistic Features and Treatments. J Clin Med 2022;11:4896. [PMID: 36013135 DOI: 10.3390/jcm11164896] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
68 Ferreira-junior AS, Borgonovi TF, De Salis LVV, Leite AZ, Dantas AS, De Salis GVV, Cruz GNF, De Oliveira LFV, Gomes E, Penna ALB, De Oliveira GLV. Detection of Intestinal Dysbiosis in Post-COVID-19 Patients One to Eight Months after Acute Disease Resolution. IJERPH 2022;19:10189. [DOI: 10.3390/ijerph191610189] [Reference Citation Analysis]
69 Chirinos J, Lopez-jaramillo P, Giamarellos-bourboulis E, Dávila-del-carpio G, Bizri A, Andrade-villanueva J, Salman O, Cure-cure C, Rosado-santander N, Giraldo MC, González-hernández L, Moghnieh R, Angeliki R, Saldarriaga MC, Pariona M, Medina C, Dimitroulis I, Vlachopoulos C, Gutierrez C, Rodriguez-mori J, Gomez-laiton E, Pereyra R, Hernández JR, Arbañil H, Accini-mendoza J, Pérez-mayorga M, Milionis H, Poulakou G, Sánchez G, Valdivia-vega R, Villavicencio-carranza M, Ayala-garcia R, Castro-callirgos C, Carrasco RA, Danos WL, Sharkoski T, Greene K, Pourmussa B, Greczylo C, Chittams J, Katsaounou P, Alexiou Z, Sympardi S, Sweitzer N, Putt M, Cohen J. A Randomized Trial of Lipid Metabolism Modulation with Fenofibrate for Acute Coronavirus Disease 2019.. [DOI: 10.21203/rs.3.rs-1933913/v1] [Reference Citation Analysis]
70 Cassiano LMG, Silva VC, Oliveira MS, Prado BVO, Cardoso CG, Salim ACM, Franco GR, D’almeida V, Francisco SC, Coimbra RS. Vitamin B12 attenuates leukocyte inflammatory signature in COVID-19 via methyl-dependent changes in epigenetic marks.. [DOI: 10.1101/2022.08.08.503231] [Reference Citation Analysis]
71 Shang Y, Wu J, Liu J, Long Y, Xie J, Zhang D, Hu B, Zong Y, Liao X, Shang X, Ding R, Kang K, Liu J, Pan A, Xu Y, Wang C, Xu Q, Zhang X, Zhang J, Liu L, Zhang J, Yang Y, Yu K, Guan X, Chen D. Expert consensus on the diagnosis and treatment of severe and critical coronavirus disease 2019 (COVID-19). Journal of Intensive Medicine 2022. [DOI: 10.1016/j.jointm.2022.07.001] [Reference Citation Analysis]
72 Bonaventura A, Potere N. Blood Hyperviscosity: A Novel Link Between Hyperinflammation and Hypercoagulability in COVID-19. J Am Coll Cardiol 2022;80:329-31. [PMID: 35863849 DOI: 10.1016/j.jacc.2022.04.061] [Reference Citation Analysis]
73 Nolan LS, Baldridge MT. Advances in understanding interferon-mediated immune responses to enteric viruses in intestinal organoids. Front Immunol 2022;13:943334. [DOI: 10.3389/fimmu.2022.943334] [Reference Citation Analysis]
74 Li X, Zhang P, Yin Z, Xu F, Yang Z, Jin J, Qu J, Liu Z, Qi H, Yao C, Shuai J. Caspase-1 and Gasdermin D Afford the Optimal Targets with Distinct Switching Strategies in NLRP1b Inflammasome-Induced Cell Death. Research 2022;2022:1-17. [DOI: 10.34133/2022/9838341] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
75 Piacentini S, Riccio A, Santopolo S, Pauciullo S, Rossi A, Rossignol J, Santoro MG. Nitazoxanide is a potent inhibitor of human seasonal coronaviruses acting at postentry level: effect on viral spike glycoprotein.. [DOI: 10.1101/2022.07.13.499346] [Reference Citation Analysis]
76 Martins M, do Nascimento GM, Nooruzzaman M, Yuan F, Chen C, Caserta LC, Miller AD, Whittaker GR, Fang Y, Diel DG. The Omicron variant BA.1.1 presents a lower pathogenicity than B.1 D614G and Delta variants in a feline model of SARS-CoV-2 infection. bioRxiv 2022:2022. [PMID: 35734088 DOI: 10.1101/2022.06.15.496220] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
77 Planchais C, Reyes-ruiz A, Lacombe R, Zarantonello A, Lecerf M, Revel M, Roumenina LT, Atanasov BP, Mouquet H, Dimitrov JD. Evolutionary trajectory of receptor binding specificity and promiscuity of the spike protein of SARS-CoV-2.. [DOI: 10.1101/2022.06.11.495733] [Reference Citation Analysis]
78 Clancy J, Hoffmann CS, Pickett BE. Transcriptomics Meta-Analysis Predicts Two Robust Human Biomarkers for Severe Infection with SARS-CoV-2.. [DOI: 10.1101/2022.06.06.22276040] [Reference Citation Analysis]
79 Chen Y, Zhang X, Zeng X, Xu T, Xiao W, Yang X, Zhan W, Zhan C, Lai K. Prevalence and risk factors for postinfectious cough in discharged patients with coronavirus disease 2019 (COVID-19). J Thorac Dis 2022;14:2079-88. [PMID: 35813767 DOI: 10.21037/jtd-21-876] [Reference Citation Analysis]
80 Bohmwald K, Andrade CA, Mora VP, Muñoz JT, Ramírez R, Rojas MF, Kalergis AM. Neurotrophin Signaling Impairment by Viral Infections in the Central Nervous System. Int J Mol Sci 2022;23:5817. [PMID: 35628626 DOI: 10.3390/ijms23105817] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
81 Nouailles G, Adler JM, Pennitz P, Peidli S, Alves GT, Baumgart M, Bushe J, Voss A, Langenhagen A, Pott F, Kazmierski J, Goekeri C, Simmons S, Xing N, Langner C, Vidal RM, Abdelgawad A, Herwig S, Cichon G, Niemeyer D, Drosten C, Goffinet C, Landthaler M, Blüthgen N, Wu H, Witzenrath M, Gruber AD, Praktiknjo SD, Osterrieder N, Wyler E, Kunec D, Trimpert J. A live attenuated vaccine confers superior mucosal and systemic immunity to SARS-CoV-2 variants.. [DOI: 10.1101/2022.05.16.492138] [Reference Citation Analysis]
82 Fischer T, El Baz Y, Graf N, Wildermuth S, Leschka S, Kleger G, Pietsch U, Frischknecht M, Scanferla G, Strahm C, Wälti S, Dietrich TJ, Albrich WC. Clinical and Imaging Features of COVID-19-Associated Pulmonary Aspergillosis. Diagnostics 2022;12:1201. [DOI: 10.3390/diagnostics12051201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Vollenberg R, Tepasse PR, Fobker M, Hüsing-Kabar A. Significantly Reduced Retinol Binding Protein 4 (RBP4) Levels in Critically Ill COVID-19 Patients. Nutrients 2022;14:2007. [PMID: 35631143 DOI: 10.3390/nu14102007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Wu TT, Travaglini KJ, Rustagi A, Xu D, Zhang Y, Jang SK, Gillich A, Dehghannasiri R, Martinez-colon G, Beck A, Wilk AJ, Morri M, Trope WL, Shrager JB, Quake SR, Kuo CS, Salzman J, Kim PS, Blish CA, Krasnow MA. Activated interstitial macrophages are a predominant target of viral takeover and focus of inflammation in COVID-19 initiation in human lung.. [DOI: 10.1101/2022.05.10.491266] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
85 黄 云. Design, Synthesis and Molecular Docking of SARS-CoV-2 3CL<sup>pro</sup> Inhibitors. HJMCe 2022;10:352-357. [DOI: 10.12677/hjmce.2022.104037] [Reference Citation Analysis]
86 Weigle AT, Feng J, Shukla D. Thirty years of molecular dynamics simulations on posttranslational modifications of proteins. Phys Chem Chem Phys 2022. [DOI: 10.1039/d2cp02883b] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Chirinos JA, Lopez-Jaramillo P, Giamarellos-Bourboulis EJ, Dávila-Del-Carpio GH, Bizri AR, Andrade-Villanueva JF, Salman O, Cure-Cure C, Rosado-Santander NR, Cornejo Giraldo MP, González-Hernández LA, Moghnieh R, Angeliki R, Cruz Saldarriaga ME, Pariona M, Medina C, Dimitroulis I, Vlachopoulos C, Gutierrez C, Rodriguez-Mori JE, Gomez-Laiton E, Cotrina Pereyra R, Ravelo Hernández JL, Arbañil H, Accini-Mendoza J, Pérez-Mayorga M, Milionis C, Poulakou G, Sánchez G, Valdivia-Vega R, Villavicencio-Carranza M, Ayala-García RJ, Castro-Callirgos CA, Alfaro Carrasco RM, Garrido Lecca Danos W, Sharkoski T, Greene K, Pourmussa B, Greczylo C, Ortega-Legaspi J, Jacoby D, Chittams J, Katsaounou P, Alexiou Z, Sympardi S, Sweitzer NK, Putt M, Cohen JB; FERMIN Investigators. A randomized clinical trial of lipid metabolism modulation with fenofibrate for acute coronavirus disease 2019. Nat Metab 2022;4:1847-57. [PMID: 36344766 DOI: 10.1038/s42255-022-00698-3] [Reference Citation Analysis]
88 Tommaso Francesco Aiello, Carolina García-Vidal, Alex Soriano. Antiviral drugs against SARS-CoV-2. Rev Esp Quimioter 2022;35. [PMID: 36285850 DOI: 10.37201/req/s03.03.2022] [Reference Citation Analysis]
89 Zarifkar P, Peinkhofer C, Kondziella D. COVID-19 and the developing brain. Reference Module in Biomedical Sciences 2022. [DOI: 10.1016/b978-0-12-818872-9.00130-8] [Reference Citation Analysis]
90 Khan B, O’laughlin A, Perelas A, Thatcher TH, Jackson PD. Polyunsaturated Fatty Acid-Derived Lipid Mediators as Biomarkers in Critical Care. Biomarkers in Trauma, Injury and Critical Care 2022. [DOI: 10.1007/978-3-030-87302-8_77-1] [Reference Citation Analysis]